Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
This Masters project is a small part of the LINEAGE study, a research consortium working on emerging ethical, legal and social issues in the governance of genomic information. Personal genomic information is valuable data. ‘Trust’ is therefore crucial for the public to provide this information
We’re researching what people need to decide if reproductive genetic carrier screening (RGCS) is right for them and creating publicly accessible resources for anyone considering this in Australia.
BabyScreen+ is a research study where parents can choose to have their baby’s heelprick sample screened for over 500 additional treatable, childhood-onset conditions. This is called genomic newborn screening. This study is investigating the best way to deliver genomic newborn screening for babies
We invite individuals between the ages of 0 and 75 with a genetic diagnosis of Leigh Syndrome to participate in our study. Researchers will collect both objective and subjective assessments of symptom involvement.
Assisted Reproductive Technologies (ART) were pioneered in Victoria and so people conceived by IVF are now up to 40 years of age. There is a widely held belief that common adult-onset disorders (particularly cardiovascular and respiratory diseases) begin in early life, possibly even before birth.
Our aim is to generate knowledge that improves the lives of individuals, families and communities affected by genetic disorders. Established in 2003, the Bruce Lefroy Centre (BLC) at the Murdoch Children’s Research Institute is dedicated to advancing research into genetic conditions. Named in
Our group examines genetic, neural, and social-environmental predictors of speech, language, and literacy development. This will lead to better diagnosis, prognosis, and treatment for children with speech and language disorders.
Our research promotes understanding of genetics and genomics, and informs evidence-based practice, among families, health professionals and the community.
Our goal is to enable earlier diagnoses and more precise, personalised treatments for inherited rare diseases. Our emphasis is on the research and development of unique technologies to improve services provided by Victorian Clinical Genetic Services (VCGS) Pathology, a wholly-owned subsidiary of
We aim to accelerate the implementation of new genomic technologies in healthcare, particularly for the benefit of children and families affected by rare disease.
Page 30 of 103
